home / stock / zntl / zntl articles

ZNTL Articles, Zentalis Pharmaceuticals Inc.

Stock Information
Company Name: Zentalis Pharmaceuticals Inc.
Stock Symbol: ZNTL
Market: NASDAQ
Menu
ZNTL ZNTL Quote ZNTL Short ZNTL News ZNTL Articles ZNTL Message Board
Get ZNTL Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financia...
Investigation Into Zentalis Pharmaceuticals, Inc. (ZNTL) Announced byHolzer & Holzer, LLC | Benzinga

ATLANTA, June 18, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zentalis Pharmaceuticals, Inc. ("Zentalis"?or the...

Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday? | Benzinga

Tuesday, Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) announced that the FDA has placed a partial clinical hold on the following studies of azen...

Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | Benzinga

NEW YORK and SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical ...
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors | Benzinga

NEW YORK and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical ...

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit | Benzinga

NEW YORK and SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical ...

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024 | Benzinga

NEW YORK and SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutica...
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences | Benzinga

NEW YORK and SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical...

Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference | Benzinga

NEW YORK and SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical...

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) and Encourages Investors to Contact the Firm | Benzinga

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) ...
Next 10